Advertisement
Advertisement
AVXL
Anavex Life Sciences
3.08
USDSponsored
+0.02
+0.65%
May 13, 16:00 UTC -4
Closed
After-Market
3.10
+0.02
+0.52%
AVXL Earnings Reports
Positive Surprise Ratio
AVXL beat 25 of 37 last estimates.
68%
Next Report
Date of Next Report
Aug 10, 2026
Estimate for Q3 26 (Revenue/ EPS)
--
/-$0.08
Implied change from Q2 26 (Revenue/ EPS)
--
/--
Implied change from Q3 25 (Revenue/ EPS)
--
/-50.00%
Anavex Life Sciences earnings per share and revenue
On May 07, 2026, AVXL reported earnings of -- USD per share (EPS) for Q2 26, -- the estimate of -0.07 USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference.
Looking ahead to Q3 26, 5 analysts forecast an EPS of -0.08 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Allogene Therapeutics, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.19
Actual
-$0.18
Surprise
+7.31%
Immunic, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.93
Actual
-$1.08
Surprise
-16.03%
Spero Therapeutics, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.18
Actual
-$0.13
Surprise
+29.19%
Equillium, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.04
Actual
-$0.06
Surprise
-34.53%
Seer, Inc. Class A Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.30
Actual
-$0.30
Surprise
+0.30%
BeyondSpring Inc. Ordinary Shares
Report Date
May 13, 2026 For Q1 26
Estimate
-Actual
-$0.05
Surprise
-
PDS Biotechnology Corporation Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.15
Actual
-$0.13
Surprise
+15.03%
Tango Therapeutics, Inc.
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.31
Actual
-$0.32
Surprise
-0.13%
Dyadic International, Inc.
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.04
Actual
-$0.05
Surprise
-22.55%
Genprex, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-Actual
-$0.64
Surprise
-
FAQ
What were Anavex Life Sciences's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Anavex Life Sciences reported EPS of --, missing estimates by --, and revenue of --, 0% as expectations.
How did the market react to Anavex Life Sciences's Q2 2026 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Anavex Life Sciences expected to report next?
The next earning report is scheduled for Aug 10, 2026.
What are the forecasts for Anavex Life Sciences's next earnings report?
Based on 5
analysts, Anavex Life Sciences is expected to report EPS of -$0.08 and revenue of -- for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement